IP Library Granted Patent US 12,415,081
Granted Patent B2
US 12,415,081 · App. 18/630,938 · Granted Sep 16, 2025

Midfield transmitter systems

Inventors: Alexander Yeh (Los Altos Hills, CA); Timothy A. Fayram (Gilroy, CA)
Assignee: NEUSPERA MEDICAL INC.
A61N1/37229A61B5/0015A61B5/0031A61B5/0205A61B5/686A61B17/3468A61N1/0558A61N1/36A61N1/36125A61N1/372A61N1/37205A61N1/3787H04B5/79A61B5/01A61B5/067A61B5/14532A61B5/24A61B5/389A61B17/1128A61B18/0206A61B18/0218A61B2018/046A61B2560/0219A61N1/025A61N1/0464A61N1/0468A61N1/0534A61N1/0556A61N1/326A61N1/36002A61N1/36007A61N1/3601A61N1/36053A61N1/36057A61N1/36071A61N1/36107A61N1/3611A61N1/36117A61N1/36121A61N1/3754H02J50/12
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,415,081
App. No.
18/630,938
Granted
Sep 16, 2025
Kind
B2
Abstract

Generally discussed herein are systems, devices, and methods for providing a therapy (e.g., stimulation) and/or data signal using an implantable device. Systems, devices and methods for interacting with (e.g., communicating with, receiving power from) an external device are also provided.

Claims (37)

1. An implantable system comprising:

a hermetic enclosure; and

a circuit assembly inside the hermetic enclosure, the circuit assembly comprising a proximal portion, a central portion, and a distal portion, wherein a first dielectric material layer comprises a portion of the proximal portion, the central portion, and the distal portion of the circuit assembly;

wherein the proximal portion comprises a first flexible region and one or more plated conductors;

wherein the distal portion comprises a second flexible region; and

wherein the central portion comprises one or more other dielectric material layers and one or more conductive material layers.

2. The implantable system of claim 1 , wherein the first dielectric material layer is a contiguous dielectric substrate that extends from a first end of the proximal portion to an opposite second end of the distal portion of the circuit assembly.

3. The implantable system of claim 2 , wherein a length of the circuit assembly from the first end to the opposite second end exceeds a length of the hermetic enclosure.

4. The implantable system of claim 2 , wherein the circuit assembly comprises a first conductive material layer disposed on the first dielectric material layer and the first conductive material layer comprises a portion of the proximal, central, and distal portions of the circuit assembly.

5. The implantable system of claim 4 , wherein the first conductive material layer comprises one or more of copper, silver, gold, titanium, platinum, aluminum, and steel.

6. The implantable system of claim 5 , wherein a length of the first dielectric material layer exceeds a length of the first conductive material layer.

7. The implantable system of claim 1 , wherein the distal portion of the circuit assembly comprises the second flexible region and one or more other plated conductors.

8. The implantable system of claim 7 , wherein the first and second flexible regions have different length characteristics.

9. The implantable system of claim 1 , wherein the first flexible region of the circuit assembly comprises an etched portion, wherein the etched portion has less rigidity than one or more other portions of the first flexible region.

10. The implantable system of claim 1 ,

wherein the hermetic enclosure includes:

a first end cap with a conductive first feedthrough coupled to the one or more plated conductors on the proximal portion of the circuit assembly; and

a second end cap with a conductive second feedthrough coupled to a conductor on the distal portion of the circuit assembly.

11. The implantable system of claim 1 , wherein the one or more plated conductors comprise one or more of silver, gold, and tin plated conductors.

12. A circuit assembly for an implantable device, the circuit assembly comprising:

a proximal portion comprising a first flexible region and one or more first plated conductors;

a distal portion comprising a second flexible region and one or more second plated conductors;

a rigid central portion comprising one or more other dielectric material layers and one or more conductive material layers; and

a first dielectric material layer comprising the proximal portion, the distal portion, and the rigid central portion of the circuit assembly.

13. The circuit assembly of claim 12 , wherein the first dielectric material layer is a contiguous dielectric substrate that extends from the proximal portion, through the central portion, and to the distal portion of the circuit assembly.

14. The circuit assembly of claim 13 , wherein the circuit assembly comprises a first conductive material layer disposed on the first dielectric material layer and the first conductive material layer comprises a portion of the proximal, central, and distal portions of the circuit assembly.

15. The circuit assembly of claim 14 , wherein the first conductive material layer comprises one or more of copper, silver, gold, titanium, platinum, aluminum, and steel.

16. The circuit assembly of claim 15 , wherein a length of the first dielectric material layer exceeds a length of the first conductive material layer.

17. The circuit assembly of claim 12 , wherein the first and second flexible regions have different length characteristics.

18. The circuit assembly of claim 12 , wherein the first flexible region of the circuit assembly comprises an etched portion, wherein the etched portion has less rigidity than one or more other portions of the first flexible region.

19. A circuit assembly for an implantable device, the circuit assembly comprising:

a proximal portion comprising a first flexible region and one or more first plated conductors;

a distal portion comprising a second flexible region and one or more second plated conductors;

a rigid central portion comprising one or more other dielectric material layers;

a first dielectric material layer comprising the proximal portion, the distal portion, and the rigid central portion of the circuit assembly; and

a first conductive material layer disposed on the first dielectric material layer and comprising the proximal portion, the distal portion, and the rigid central portion of the circuit assembly.

20. The circuit assembly of claim 19 , wherein the first dielectric material layer is a contiguous dielectric member that extends from the proximal portion, through the central portion, and to the distal portion of the circuit assembly.

Assignments (2)
SECURITY INTEREST Recorded May 18, 2026
From: NEUSPERA MEDICAL INC.
To: FIRST-CITIZENS BANK & TRUST COMPANY
Reel/Frame 075589/0305 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2024
From: YEH, ALEXANDER JUESHYAN; FAYRAM, TIMOTHY A.
To: NEUSPERA MEDICAL INC.
Reel/Frame 067151/0501 →
Continuity (11)
Continuation 17454214 · Nov 9, 2021
Continuation 16435073 · Jun 7, 2019
Continuation 16004894 · Jun 11, 2018
Continuation PCTUS2018016051 · Jan 30, 2018
Provisional Application 62452052 · Jan 30, 2017
Provisional Application 62515220 · Jun 5, 2017
Provisional Application 62511075 · May 25, 2017
Provisional Application 62512560 · May 30, 2017
Provisional Application 62562023 · Sep 22, 2017
Provisional Application 62598855 · Dec 14, 2017
Related Publication 20250001188A1 · Jan 2, 2025
References Cited (164)
US 4943809A · Zaghloul · 1990 [cited by applicant]
US 7191013B1 · Miranda et al. · 2007 [cited by applicant]
US 7202790B2 · Copeland et al. · 2007 [cited by applicant]
US 8634928B1 · O'Driscoll et al. · 2014 [cited by applicant]
US 9461648B1 · Lee et al. · 2016 [cited by applicant]
US 10485980B2 · Yeh et al. · 2019 [cited by applicant]
US 10561842B2 · Yeh et al. · 2020 [cited by applicant]
US 11198011B2 · Yeh et al. · 2021 [cited by applicant]
US 11596794B2 · Yeh et al. · 2023 [cited by applicant]
US 11986662B2 · Yeh et al. · 2024 [cited by applicant]
US 20040140863A1 · Ammar · 2004 [cited by applicant]
US 20040250820A1 · Forsell · 2004 [cited by applicant]
US 20050105917A1 · Narusawa et al. · 2005 [cited by applicant]
US 20060038597A1 · Becker et al. · 2006 [cited by applicant]
US 20060253107A1 · Hashimshony et al. · 2006 [cited by applicant]
US 20070080864A1 · Channabasappa · 2007 [cited by applicant]
US 20080269740A1 · Bonde et al. · 2008 [cited by applicant]
US 20090284220A1 · Toncich et al. · 2009 [cited by applicant]
US 20100109966A1 · Mateychuk et al. · 2010 [cited by applicant]
US 20110148519A1 · Drogi et al. · 2011 [cited by applicant]
US 20110166629A1 · Dion et al. · 2011 [cited by applicant]
US 20120119698A1 · Karalis et al. · 2012 [cited by applicant]
US 20120309237A1 · Marzano et al. · 2012 [cited by applicant]
US 20130274820A1 · Malinowski et al. · 2013 [cited by applicant]
US 20140031837A1 · Perryman et al. · 2014 [cited by applicant]
US 20140031903A1 · Mashiach · 2014 [cited by applicant]
US 20140036409A1 · Stevenson et al. · 2014 [cited by applicant]
US 20140203823A1 · Joshi · 2014 [cited by applicant]
US 20150066155A1 · Haque · 2015 [cited by applicant]
US 20150088226A1 · Tourrel et al. · 2015 [cited by applicant]
US 20150265842A1 · Ridler et al. · 2015 [cited by applicant]
US 20160344238A1 · Yeh et al. · 2016 [cited by applicant]
US 20170001003A1 · Pivonka et al. · 2017 [cited by applicant]
US 20170095667A1 · Yakovlev et al. · 2017 [cited by applicant]
US 20170271919A1 · Von Novak, III et al. · 2017 [cited by applicant]
US 20180071540A1 · Poon et al. · 2018 [cited by applicant]
US 20180085593A1 · Fayram et al. · 2018 [cited by applicant]
US 20180289971A1 · Yeh et al. · 2018 [cited by applicant]
US 20180294676A1 · Davlantes · 2018 [cited by applicant]
US 20190184159A1 · Yeh et al. · 2019 [cited by applicant]
US 20190290923A1 · Yeh et al. · 2019 [cited by applicant]
US 20200155843A1 · Yeh et al. · 2020 [cited by applicant]
US 20210361940A1 · Yeh et al. · 2021 [cited by applicant]
US 20220062651A1 · Yeh et al. · 2022 [cited by applicant]
AU 2018213427B2 · 2020 [cited by applicant]
AU 2019252904B2 · 2022 [cited by applicant]
AU 2021254572B2 · 2024 [cited by applicant]
CA 3052093C · 2023 [cited by applicant]
CN 1942140A · 2007 [cited by applicant]
CN 101687092A · 2010 [cited by applicant]
CN 101912666A · 2010 [cited by applicant]
CN 102769440A · 2012 [cited by applicant]
CN 110461218A · 2019 [cited by applicant]
CN 112673567A · 2021 [cited by applicant]
EP 3573519A1 · 2019 [cited by applicant]
JP H0497604A · 1992 [cited by applicant]
JP H04183003A · 1992 [cited by applicant]
JP H06334427 · 1994 [cited by applicant]
JP H07162227A · 1995 [cited by applicant]
JP 2000508144A · 2000 [cited by applicant]
JP 2008505569 · 2008 [cited by applicant]
JP 2012508622A · 2012 [cited by applicant]
JP 2013521676A · 2013 [cited by applicant]
JP 2014500097A · 2014 [cited by applicant]
JP 2016149783A · 2016 [cited by applicant]
JP 2016538090A · 2016 [cited by applicant]
JP 2018514366A · 2018 [cited by applicant]
JP 2018532501A · 2018 [cited by applicant]
JP 7050795B2 · 2022 [cited by applicant]
JP 7301180B2 · 2023 [cited by applicant]
WO WO2011024355A1 · 2011 [cited by applicant]
WO WO2011089676A1 · 2011 [cited by applicant]
WO WO2015039108A2 · 2015 [cited by applicant]
WO WO2015196164A2 · 2015 [cited by applicant]
WO WO2015179225A1 · 2015 [cited by applicant]
WO WO2017070372A1 · 2017 [cited by applicant]
WO WO2018140983A1 · 2018 [cited by applicant]
WO WO2019200285A1 · 2019 [cited by applicant]
“U.S. Appl. No. 16/004,894, 312 Amendment filed Jul. 17, 2019”, 4 pgs. [cited by applicant]
“U.S. Appl. No. 16/004,894, Notice of Allowance mailed Jun. 12, 2019”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/004,894, Response filed May 6, 2019 to Restriction Requirement mailed Apr. 3, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/004,894, Restriction Requirement mailed Apr. 3, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/220,815, Non Final Office Action mailed Sep. 10, 2019”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/220,815, Notice of Allowance mailed Dec. 11, 2019”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/220,815, Response filed Jun. 24, 2019 to Restriction Requirement—Prioritized Examination mailed May 21, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/220,815, Response filed Sep. 27, 2019 to Non-Final Office Action mailed Sep. 10, 2019”, 10 pgs. [cited by applicant]
“U.S. Appl. No. 16/435,073, Non Final Office Action mailed May 17, 2021”, 11 pgs. [cited by applicant]
“U.S. Appl. No. 16/435,073, Notice of Allowance mailed Nov. 5, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/435,073, Response filed Mar. 22, 2021 to Restriction Requirement mailed Jan. 22, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 16/435,073, Response filed Oct. 12, 2021 to Non Final Office Action mailed May 17, 2021”, 13 pgs. [cited by applicant]
“U.S. Appl. No. 16/435,073, Restriction Requirement mailed Jan. 22, 2021”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/722,593, Corrected Notice of Allowability mailed Feb. 1, 2023”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/722,593, Non Final Office Action mailed May 12, 2022”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/722,593, Notice of Allowability mailed Nov. 10, 2022”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 16/722,593, Notice of Allowance mailed Nov. 1, 2022”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 16/722,593, Preliminary Amendment filed Feb. 7, 2020”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 16/722,593, Response filed Jun. 9, 2021 to Restriction Requirement mailed Apr. 9, 2021”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 16/722,593, Restriction Requirement mailed Apr. 9, 2021”, 8 pgs. [cited by applicant]
“U.S. Appl. No. 17/046,687, Non Final Office Action mailed Oct. 27, 2022”, 17 pgs. [cited by applicant]
“U.S. Appl. No. 17/046,687, Response filed Jun. 13, 2022 to Restriction Requirement mailed Apr. 13, 2022”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/046,687, Restriction Requirement mailed Apr. 13, 2022”, 9 pgs. [cited by applicant]
“U.S. Appl. No. 17/454,214, Corrected Notice of Allowability mailed Apr. 24, 2024”, 2 pgs. [cited by applicant]
“U.S. Appl. No. 17/454,214, Non Final Office Action mailed Sep. 12, 2023”, 5 pgs. [cited by applicant]
“U.S. Appl. No. 17/454,214, Notice of Allowance mailed Jan. 9, 2024”, 7 pgs. [cited by applicant]
“U.S. Appl. No. 17/454,214, Response filed Dec. 8, 2023 to Non Final Office Action mailed Sep. 12, 2023”, 7 pgs. [cited by applicant]
“Australian Application Serial No. 2018213427, First Examination Report mailed Oct. 25, 2019”, 3 pgs. [cited by applicant]
“Australian Application Serial No. 2018213427, Response filed Dec. 18, 2019 to First Examination Report mailed Oct. 25, 2019”, 9 pgs. [cited by applicant]
“Australian Application Serial No. 2019252904, First Examination Report mailed Nov. 5, 2021”, 5 pgs. [cited by applicant]
“Australian Application Serial No. 2019252904, Response Filed Apr. 6, 2022 to First Examination Report mailed Nov. 5, 2021”, 10 pgs. [cited by applicant]
“Australian Application Serial No. 2020203672, First Examination Report mailed May 25, 2021”, 3 pgs. [cited by applicant]
“Australian Application Serial No. 2020203672, Response filed Jun. 21, 2021 to First Examination Report mailed May 25, 2021”, 217 pgs. [cited by applicant]
“Australian Application Serial No. 2021254572, First Examination Report mailed Oct. 6, 2022”, 3 pgs. [cited by applicant]
“Australian Application Serial No. 2021254572, Response Filed May 8, 2023 to First Examination Report mailed Oct. 6, 2022”, 13 pgs. [cited by applicant]
“Australian Application Serial No. 2021254572, Response Filed Sep. 15, 2023 to Subsequent Examiners Report mailed May 22, 2023”, 7 pgs. [cited by applicant]
“Australian Application Serial No. 2021254572, Subsequent Examiners Report mailed May 22, 2023”, 3 pgs. [cited by applicant]
“Canadian Application Serial No. 3,052,093, Non Final Office Action mailed May 16, 2022”, 3 pgs. [cited by applicant]
“Canadian Application Serial No. 3,052,093, Office Action mailed Aug. 6, 2021”, 4 pgs. [cited by applicant]
“Canadian Application Serial No. 3,052,093, Office Action mailed Oct. 1, 2020”, 6 pgs. [cited by applicant]
“Canadian Application Serial No. 3,052,093, Response filed Jan. 29, 2021 to Office Action mailed Oct. 1, 2020”, 21 pgs. [cited by applicant]
“Canadian Application Serial No. 3,052,093, Response filed Dec. 3, 2021 to Office Action mailed Aug. 6, 2021”, 20 pgs. [cited by applicant]
“Canadian Application Serial No. 3,052,093, Response Filed Sep. 12, 2022 to Non Final Office Action mailed May 16, 2022”, 9 pgs. [cited by applicant]
“Canadian Application Serial No. 3,096,463, Office Action mailed Oct. 20, 2021”, 5 pgs. [cited by applicant]
“Canadian Application Serial No. 3,096,463, Response filed Feb. 17, 2022 to Office Action mailed Oct. 20, 2021”, 17 pgs. [cited by applicant]
“Canadian Application Serial No. 3096483, Examiner's Rule 86 2 Requisition mailed Nov. 4, 2022”, 4 pgs. [cited by applicant]
“Chinese Application Serial No. 201880021261.8, Decision of Rejection mailed Apr. 8, 2022”, with English translation, 15 pages. [cited by applicant]
“Chinese Application Serial No. 201880021261.8, Office Action mailed Aug. 25, 2021”, with English translation, 15 pages. [cited by applicant]
“Chinese Application Serial No. 201880021261.8, Office Action mailed Dec. 20, 2021”, with English translation, 13 pages. [cited by applicant]
“Chinese Application Serial No. 201880021261.8, Response filed Feb. 7, 2022 to Office Action mailed Dec. 20, 2021”, with English claims, 11 pages. [cited by applicant]
“Chinese Application Serial No. 201880021261.8, Response filed Oct. 14, 2021 to Office Action mailed Aug. 25, 2021”, with English claims, 11 pages. [cited by applicant]
“Chinese Application Serial No. 201880021261.8, Response Filed Jul. 19, 2022 to Decision of Rejection mailed Apr. 8, 2022”, W/ English Claims, 13 pgs. [cited by applicant]
“Chinese Application Serial No. 201980039503.0, Office Action mailed Jan. 13, 2021”, with English translation, 2 pages. [cited by applicant]
“European Applicatioin Serial No. 18745034.1, Response filed Mar. 27, 2020 to Communication Pursuant to Rules 161(1) and 162 EPC mailed Oct. 11, 2019”, 31 pgs. [cited by applicant]
“European Application Serial No. 18745034.1, Communication Pursuant to Article 94(3) EPC mailed Nov. 7, 2023”, 4 pgs. [cited by applicant]
“European Application Serial No. 18745034.1, Extended European Search Report mailed Dec. 9, 2020”, 7 pgs. [cited by applicant]
“European Application Serial No. 18745034.1, Response Filed Mar. 6, 2024 to Communication Pursuant to Article 94(3) EPC mailed Nov. 7, 2023”, 7 pgs. [cited by applicant]
“European Application Serial No. 19785104.1, Extended European Search Report mailed Apr. 5, 2022”, 13 pgs. [cited by applicant]
“European Application Serial No. 19785104.1, Partial Supplementary European Search Report mailed Dec. 10, 2021”, 12 pgs. [cited by applicant]
“European Application Serial No. 19785104.1, Response to Communication pursuant to Rules 161(2) and 162 EPC filed May 26, 2021”, 38 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/016051, International Preliminary Report on Patentability mailed Aug. 8, 2019”, 9 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/016051, International Search Report mailed May 10, 2018”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/016051, Invitation to Pay Add'l Fees and Partial Search Rpt mailed Mar. 23, 2018”, 2 pgs. [cited by applicant]
“International Application Serial No. PCT/US2018/016051, Written Opinion mailed May 10, 2018”, 7 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/027270, International Preliminary Report on Patentability mailed Jul. 27, 2020”, 10 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/027270, International Search Report mailed Aug. 19, 2019”, 5 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/027270, Invitation to Pay Additional Fees mailed Jun. 19, 2019”, 3 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/027270, Response to Written Opinion filed Feb. 12, 2020 to Written Opinion mailed Aug. 19, 2019”, 41 pgs. [cited by applicant]
“International Application Serial No. PCT/US2019/027270, Written Opinion mailed Aug. 19, 2019”, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2019-541245, Examiners Decision of Final Refusal mailed Sep. 28, 2021”, with English translation, 7 pages. [cited by applicant]
“Japanese Application Serial No. 2019-541245, Notification of Reasons for Refusal mailed May 11, 2021”, with English translation, 6 pages. [cited by applicant]
“Japanese Application Serial No. 2019-541245, Office Action mailed Aug. 24, 2021”, with machine English translation, 5 pages. [cited by applicant]
“Japanese Application Serial No. 2019-541245, Response filed Jan. 13, 2022 to Examiners Decision of Final Refusal mailed Sep. 28, 2021”, with English claims, 20 pages. [cited by applicant]
“Japanese Application Serial No. 2019-541245, Response filed Aug. 6, 2021 to Notification of Reasons for Refusal mailed May 11, 2021”, with English claims, 14 pages. [cited by applicant]
“Japanese Application Serial No. 2020-554854, Examiners Decision of Final Refusal mailed Sep. 27, 2022”, w/ English Translation, 15 pgs. [cited by applicant]
“Japanese Application Serial No. 2020-554854, Notification of Reasons for Refusal mailed Feb. 1, 2022”, with English translation, 13 pages. [cited by applicant]
“Japanese Application Serial No. 2020-554854, Response Filed Apr. 4, 2022 to Notification of Reasons for Refusal mailed Feb. 1, 2022”, W/ English Claims, 11 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-003778, Notification of Reasons for Refusal mailed Nov. 15, 2022”, w/ English translation, 9 pgs. [cited by applicant]
“Japanese Application Serial No. 2022-003778, Response Filed Feb. 13, 2023 to Notification of Reasons for Refusal mailed Nov. 15, 2022”, W/ English Claims, 11 pgs. [cited by applicant]
“Japanese Application Serial No. 2023-100501, Notification of Reasons for Refusal mailed Feb. 20, 2024”, w/ English Translation, 13 pgs. [cited by applicant]
“Japanese Application Serial No. 2023-100501, Response filed Jul. 16, 2024 to Notification of Reasons for Refusal mailed Feb. 20, 2024”, w/ current English claims, 10 pgs. [cited by applicant]
“Near and far field”, Wikipedia contributors, The Free Encyclopedia, Retrieved from the Internet: < URL: https://en.wikipedia.org/wiki/Near_and_far_field>, (Accessed Sep. 4, 2019), 11 pages. [cited by applicant]
“Stripline”, Wikipedia contributors, Wikipedia, The Free Encyclopedia, [Online]. Retrieved from the Internet: < URL: https://en.wikipedia.org/wiki/Stripline>, (Accessed Sep. 4, 2019), 3 pages. [cited by applicant]
“Japanese Application Serial No. 2023-100501, Notification of Reasons for Refusal mailed Oct. 8, 2024”, w English Translation, 10 pages. [cited by applicant]
“Japanese Application Serial No. 2023-100501, Response Filed Dec. 24, 2024 to Notification of Reasons for Refusal mailed Oct. 8, 2024”, w English Claims, 9 pages. [cited by applicant]
“Japanese Application Serial No. 2023-100501, Examiners Decision of Final Refusal mailed Mar. 18, 2025”, w English translation, 3 pages. [cited by applicant]